COMMUNIQUÉS West-GlobeNewswire

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
23/09/2025
Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the [...]
FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa
23/09/2025
HOUSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
23/09/2025
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
23/09/2025
WARREN, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today highlights emerging scientific evidence linking persistent viral reservoirs to Long COVID, and [...]
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
23/09/2025
Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a [...]
PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.
23/09/2025
TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) -- PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the company’s SHIELD Study, participated in a national roundtable on Long COVID [...]
Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support
23/09/2025
Internationally recognized researcher in medical safety and privacy, former Chief Scientist (Informatics) and CIO at the FDA, brings scientific and regulatory leadership to Shotsy PORTLAND, Ore., Sept. 23, 2025 (GLOBE [...]
AAMI Foundation Awards Grants to Hospital, University Research Teams
23/09/2025
Grants will support research at Children's Hospital of Philadelphia, University of Maryland, University of Massachusetts Amherst Arlington, Virginia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The AAMI Foundation today [...]
X-Chem Launches Chemomics: Applying Omics-Scale Chemistry Data to Yield New Candidate-Quality Molecules
23/09/2025
Intersection of best-in-class DEL, medicinal chemistry and innovative computation sciences launches era of high-throughput insights for drug discovery WALTHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global [...]
LogicMark Launches Predictive Activity Metrics in Freedom Alert Max Device
23/09/2025
Revolutionary AI-powered technology shifts from reactive emergency response to proactive fall prevention through continuous health monitoring LOUISVILLE, Ky., Sept. 23, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: [...]
PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials
23/09/2025
BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI UC 1 , an advanced AI model for Ulcerative Colitis (UC) histology endpoint [...]
Confluent Health Appoints Jim Greenwood as New Board Chair
23/09/2025
Veteran healthcare executive to lead Board of Directors as company accelerates national growth in musculoskeletal care LOUISVILLE, Ky., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Confluent Health , a national leader in [...]
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
23/09/2025
Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc, ( OTC:FITY ) a Nevada-based holding [...]
Major Shareholder Announcement
23/09/2025
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; September 23, 2025 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
23/09/2025
WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
23/09/2025
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Plum Tree Leads the Way in Team-Based Child Therapy and Multidisciplinary Testing
23/09/2025
ST. CHARLES, IL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Plum Tree Psychology, a trusted child and family mental health practice in St. Charles, IL, is proud to announce the launch of its multidisciplinary evaluation service [...]
H.H.C. Group Launches “Proof in the Pudding” Savings Program for Prospective Client TPAs, Stop-Loss and Self-Insured Payors
23/09/2025
ROCKVILLE, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment solutions, proudly announces the launch of its new “Proof in the [...]
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
23/09/2025
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]

Pages